Safety of nitric oxide added to the ECMO circuit: a pilot study in children

“

Animal and human studies identify NO an important mediator of acute ischemia and reperfusion injury at the cellular level. Adding NO to the ECMO circuit could potentially mitigate this response and improve end-organ function after ECLS initiation. Furthermore it reduced platelet aggregation and improve circuit clot formation.

”